Frontlight ResearchEarly access
Institution
The Rogosin Institute
Also known as: RI
- 5running trials
- 3closed trials
- 698publications (OpenAlex)
Running trials
Recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Polycystic kidney disease2 recruiting
- Chronic kidney disease1 recruiting
- IgA nephropathy1 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
The Rogosin Institute
New York, New York 10019
7 trials
Rogosin Institute
New York, New York 10021
2 trials
Contact: Calico Clinical Trial Communication
NCT04571619HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Institution data: ROR 05dvpaj72 (CC0-1.0)Updated 3 Nov 2026